Phreesia, Inc. (PHR) Dividend History

Phreesia, Inc. is a technology company that provides a cloud-based platform aimed at streamlining patient intake and engagement for healthcare providers. Founded in 2005, the company offers solutions for patient registration, insurance eligibility verification, billing, and clinical workflows, helping healthcare organizations improve operational efficiency and patient experience. Its platform is widely used in outpatient settings, including medical practices and health systems.

1521 Concord Pike, Wilmington, DE, 19803
Phone: 888-654-7473

Dividend History

Phreesia, Inc. currently does not pay dividends

Company News

  • Providing a diverse range of perspectives from bullish to bearish, 6 analysts have published ratings on Phreesia (NYSE:PHR) in the last three months. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 2 0 0 0 Last 30D 1 0 0 0 0 1M Ago 1 0 0 0 0 2M Ago 2 2 0 0 0 3M Ago 0 0 0 0 0 Insights from analysts' 12-month price targets are revealed, presenting an average target of $29.83, a high estimate of $34.00, and a low estimate of $28.00. A decline of 4.79% from the prior average price target is evident in the current average. Decoding Analyst Ratings: A Detailed Look In examining recent analyst actions, we gain insights into how financial experts perceive Phreesia. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Jailendra Singh Truist Securities Maintains Buy $29.00 $29.00 Jailendra Singh Truist Securities Lowers Buy $29.00 $35.00 Richard Close Canaccord Genuity Lowers Buy $34.00 $37.00 Jeff Garro Stephens & Co. Maintains Overweight $28.00 $28.00 Joe Goodwin JMP Securities Maintains Market Outperform $30.00 $30.00 Ryan MacDonald Needham Maintains Buy $29.00 $29.00 Key Insights: Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Phreesia. This information provides a snapshot of how analysts perceive the current state of the company. Rating: ...Full story available on Benzinga.com

    Benzinga
  • Tap five stocks with increasing P/E ratios to try out a different approach. These stocks include CLEAR Secure (YOU), Applied DNA Sciences (APDN), Phreesia (PHR), Vigil Neuroscience (VIGL) and Biodesix (BDSX).

    Zacks Investment Research
    Featured Companies: APDN BDSX VIGL YOU
Page data last updated 07/23/2025 09:58:20 UTC